Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1479 of 5804
-
New combo therapy may stop stroke from getting worse
Disease control CompletedPerforating artery territorial infarction (PAI) refers to a single ischemic lesion in a single perforating arterial territory and branch atheromatous disease (BAD) is an important type. BAD related stroke accounts for 10%-15% ischemic cerebral infarction and is closely related to…
Phase: PHASE4 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New study to reveal how well mpox vaccine works in HIV patients
Knowledge-focused ENROLLING_BY_INVITATIONThe goal of this study is to assess the immune response, tolerance, and safety of the low-dose intradermal (forearm) mpox vaccine in people who are HIV+ compared to people who are HIV-, and compared to the standard-dose subcutaneous (upper arm) vaccine. The resulting data will fi…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Experimental pill takes on deadliest brain tumor
Disease control OngoingThis is a phase 1 investigational study to assess the safety and preliminary efficacy of oral gallium maltolate (GaM) in participants with relapsed glioblastoma (GBM).
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Tailored therapy for medulloblastoma shows promise but trial cut short
Disease control TerminatedMedulloblastoma is a rare brain malignancy, mainly affecting children. Treatment of this rapidly growing tumor begins with maximal surgical removal plus radiation and chemotherapy. Treatment toxicity is high. Post-pubertal and pediatric medulloblastomas are biologically and progn…
Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Cooling sleeve could shield cancer patients from chemo nerve pain
Prevention Recruiting nowThe study conducted on cancer patients is designed to test safety and efficacy of limb hypothermia in cancer patients using the new Paxman Limb Cryocompression System (PLCS). Ultimately this will lead to the development of a therapy regime that will help to prevent chemotherapy-i…
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
New diabetes program helps latinx patients better manage blood sugar
Disease control CompletedDetermine the impact of the Compañeros en Salud (Partners in Health) curriculum in conjunction with RT-CGM on glycemic control in Latinx patients with T2D. Participants will be randomized to receive the Companeros en Salud diabetes self-management education and support (DSMES) in…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Sound waves to zap high blood pressure: new device trial begins
Disease control OngoingThis is a prospective, multicenter, non-randomized, open-label clinical study of the safety and performance of the TIVUS™ System in subjects with uncontrolled stage 2 hypertension in order to assess the safety and effectiveness of the TIVUS™ System when used for renal artery dene…
Phase: NA • Sponsor: SoniVie Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug combo shows promise for rare childhood muscle disease
Disease control CompletedThe MYOCIT study aims to evaluate the efficacy and safety of baricitinib in association with corticosteroids in new-onset patients with juvenile dermatomyositis (JDM) in a phase II trial with the objective to obtain a better efficacy than the conventional combination methotrexate…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New stent system aims to tame dangerous aortic aneurysms
Disease control Recruiting nowThe goal of this observational study is to collect clinical information on how safe, and how well the NEXUS Aortic Arch Stent Graft System and the Custom-Made NEXUS DUO™ Aortic Arch Stent Graft System work for the treatment of aortic aneurysms, in the standard-of-care setting. T…
Sponsor: Endospan Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New COVID booster vaccine shows promise in large trial
⭐️ VACCINE ⭐️ CompletedThis is a phase II/III parallel, double-blind, active-controlled, non-inferiority study to evaluate immunogenicity and safety of a booster immunization scheme of a single intramuscular dose of the recombinant vaccine against SARS-CoV-2 (AVX/COVID-12 vaccine) based on live recombi…
Phase: PHASE2, PHASE3 • Sponsor: Laboratorio Avi-Mex, S.A. de C.V. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:52 UTC
-
Can a common asthma drug stop post-transplant fevers?
Disease control Recruiting nowThe purpose of this study is to determine if budesonide prophylaxis starting day 5 after transplant reduces engraftment fever in autologous and allogeneic stem cell transplant recipients.
Phase: PHASE3 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for kids with kidney disease: finerenone safety trial underway
Disease control Recruiting nowResearchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney disease, and proteinuria, a condition in which a person´s kidneys leak protein into the urine. The kidneys filter waste and fluid from the blood to form ur…
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can cash incentives on your phone help you quit smoking?
Disease control CompletedThe purpose of the proposed project is to evaluate an automated mobile phone-based CM approach that will allow socioeconomically disadvantaged individuals to remotely benefit from financial incentives for smoking cessation. The investigators have previously combined technologies …
Phase: NA • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Heart attack recovery: can an Iron-Removing drug help?
Disease control Recruiting nowThe objective of this randomized, controlled pilot study is to determine the efficacy of Deferiprone to reduce the amount of free iron inside the hemorrhagic zone of myocardial infarction among hemorrhagic myocardial infarction patients.
Phase: PHASE2 • Sponsor: Rohan Dharmakumar • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can a 15-Day course of paxlovid ease long COVID?
Symptom relief CompletedThe purpose of this study is to compare whether being treated with nirmatrelvir plus ritonavir for 15 days works better than being treated with placebo plus ritonavir to reduce severe symptoms of Long Covid. Participants will have 5 planned visits to the study clinic over 15 wee…
Phase: PHASE2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 26, 2026 13:47 UTC
-
Could a simple gel replace surgery for HPV-Related cervical changes?
Disease control CompletedHuman papillomaviruses (HPV) are the most common sexually transmitted pathogens worldwide and in most cases are causally associated with the development of cervical cancer, one of the most common cancers in women and one of the leading causes of death in women worldwide. Precance…
Phase: NA • Sponsor: Ruhr University of Bochum • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New pill could tame severe gut disease
Disease control OngoingThis study is a multicenter, randomized, double-blind study. There are three dosage groups: Hemay005 45 mg BID group, 60 mg BID group or placebo group, with 36 patients in each dosage group. All patients will enter a 12-week double-blind treatment period. All subjects who have re…
Phase: PHASE2 • Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New epilepsy drug shows promise in long-term safety trial
Disease control CompletedThe objective of this study is to assess the long-term safety, tolerability, and efficacy of adjunctive therapy of LP352 in subjects with developmental and epileptic encephalopathies who completed participation in Study LP352-201.
Phase: PHASE2 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New asthma drug shows promise in small trial
Disease control CompletedIn adult patients with uncontrolled moderate-to-severe asthma, blocking TSLP with tezepelumab will improve ventilation heterogeneity (evaluated by hyperpolarized 129Xe MRI), and this will be associated with reduced airway inflammation (evaluated by sputum composition), luminal na…
Phase: PHASE3 • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a smartphone qigong program heal the mental toll of COVID-19?
Symptom relief CompletedThis study examines the effectiveness of a 16-week Integrated Mindfulness-based Health Qigong (iMBHQ) program, delivered via a mobile application, in improving the mental and physical well-being of COVID-19 survivors, their caregivers, and the general public. We hypothesize that …
Phase: NA • Sponsor: TSANG Hector Wing-Hong • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC